MedTrace Logo

Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine Gum

NCT01368016 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 346

Last updated 2012-07-10

No results posted yet for this study

Summary

A comparison of two products for oral nicotine replacement with respect to relief of urges to smoke after single doses of nicotine.

Conditions

  • Tobacco Dependence

Interventions

DRUG

Nicotine

A single 6 mg dose of an experimental Nicotine Replacement Therapy (NRT), with a 36-hour washout between visits

DRUG

Nicotine

A single 4 mg dose of a marketed Nicotine Gum, with a 36-hour washout between visits

Sponsors & Collaborators

  • McNeil AB

    lead INDUSTRY

Principal Investigators

  • Elisabeth Kruse, PhD · McNeil AB

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01368016 on ClinicalTrials.gov